We manage the full INVIMA registration process in Colombia for pharmaceuticals, biologics, medical devices and cosmetics. From dossier preparation to final approval — bilingual team, 15+ years of experience working with international companies from India, the US and Europe.
We support every stage of the regulatory process in Colombia — from first registration to post-approval modifications and specialized services.
We manage the full registration process — technical dossier preparation, filing, response to regulatory requirements and follow-up until approval.
Classification and registration before INVIMA for risk class I, II, III and IV devices. Includes in vitro diagnostic reagents and technical or legal modifications.
View service →We facilitate access to essential medicines unavailable in the Colombian market — global sourcing, import management and case-by-case follow-up.
View service →Full pharmaceutical supply chain management in Colombia — importation, specialized storage and national distribution with complete regulatory compliance.
View service →We keep your company informed about regulatory changes in Colombia — early alerts, impact analysis, strategic reports and international benchmarking.
View service →We don't just process paperwork. We build clear regulatory pathways so your product reaches the Colombian market without unnecessary roadblocks.
Pharmaceutical regulatory dossiers contain your most sensitive intellectual property — formulations, clinical data, manufacturing processes. We take that seriously. All analysis runs locally on our own systems. No cloud uploads. No third-party AI processing. Ever.
We manage the full process to obtain your sanitary registration — dossier preparation, filing and follow-up before INVIMA until approval.
View pre-approval activities →We keep your registration current and up to date — technical and legal modifications, renewals and any post-approval changes your product requires.
View post-approval services →Tell us about your product. We'll respond within 24 hours with a clear regulatory path forward.